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Introduction
The TTP family of tandem zinc finger proteins includes TTP/
ZFP36, TIS11b/ZFP36L1 and TIS11d/ZFP36L2, all of which 
have been shown to directly bind AU-rich elements (ARE) and 
promote degradation of the host transcript.1,2 Their central RNA-
binding domain interacts with AU-rich elements (UUA UUU 
AUU), whereas the N- and C-terminal domains recruit enzymes 
involved in the mRNA degradation pathway. Expression of all 
TTP family members genes can be induced by various mitogenic 
stimuli, such as growth factors, in a broad variety of cell types.3,4 
For instance, it has been demonstrated that ZFP36 binds to 
and destabilizes the TNFα, GM-CSF and VEGF mRNAs.1,5,6 
This, in turn, affects the function of transcription factors such 
as NFκB and HIF-1, which have an important impact on cell 
viability.7,8 Several publications demonstrate that TTP fam-
ily proteins are phosphorylated9 and are possible targets along 
the p38 MAPK pathway.10,11 At the biological level, TTP fam-
ily members have been described as involved in cell differentia-
tion and apoptosis,12,13 in the regulation of the cell response to 
growth factors and in the development of cancer. In particular, it 
has been demonstrated that TTP proteins target and destabilize 
mRNAs encoding growth factors’ signaling transducers, par-
ticularly downstream of EGF14 and IGF-I receptors.4 Moreover, 
it has been recently suggested that members of this family are 
also capable of acting by ARE-mediated decay-independent 
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mechanisms. For instance ZFP36 is able to terminate NFκB 
signaling by directly interfering with the nuclear import of the 
p65 subunit of the transcription factor.15 As regards cancer biol-
ogy, it has been shown that ZFP36 may alter the tumorigenic 
phenotype and patient prognosis,16 probably targeting several 
oncogenes. ZFP36 is downregulated in many cancers, and, in 
particular, it has been shown that ZFP36 is hyperphosphorylated 
and therefore inactive in gliomas,17 this leading to stabilization of 
VEGF and IL-8 mRNAs.
Glioblastoma multiforme (GBM) is the most common and 
malignant subset of brain tumors; thus, understanding the mech-
anisms mediating cellular survival and apoptosis resistance will 
enable to design smarter drug combinations in targeted cancer 
therapies. GBMs have been traditionally defined as two clinically 
and cytogenetically distinct diseases, the primary or de novo vs. 
the secondary GBMs. The latter classically afflict younger per-
sons (median age ~45 y) and evolve from the slow progression 
(mean, 4–5 y) of a low-grade glioma, which usually displays 
aberrations in platelet-derived growth factor receptor (PDGFR) 
and Tp53 genes. Primary GBMs present acutely as a high-grade 
disease that most frequently affects the elderly. They typically 
harbor mutations in epidermal growth factor receptor (EGFR), 
cyclin-dependent kinase inhibitor 2A (CDKN2A) and loss of 
heterozygosity (LOH) on chromosome 10q23, which houses the 
phosphatase and tensin homolog (PTEN) gene. LOH on chro-
mosome 10 is the most frequent genetic alteration in primary 
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GBMs, occurring in 60–80% of cases.18 Mutations in 
the EGF receptor result in ligand-independent consti-
tutive tyrosine kinase activity that activates persistent 
downstream RAS/RAF/MAPK growth and PI3K 
survival signaling.19 As regards the invasion potential 
of glioblastomas, extensive studies show that STAT3 
(through JAK/Stat pathway) and NFκB transcription 
factors support migratory and invasive potential of 
glioblastoma cells.20,21 In particular, constitutive NFκB 
activity positively regulates the expression of VEGF and 
IL-8 and tumor angiogenesis of human glioblastoma.22 
Although much is known about the diverse genotypes 
causing the heterogeneous histological phenotypes 
of GBMs and how they impact on survival signaling, 
there is still no therapy that induces tumor cell apop-
tosis beyond that of the standard treatment. Several 
studies on GBM clearly demonstrate that targeting of 
IAPs (inhibitor of apoptosis proteins) sensitizes cells 
to apoptosis,23 and a recent report showed that XIAP 
inhibitors synergize with radiation to increase glioblas-
toma cell apoptosis.24,25 Furthermore, targeting of IAPs 
also increases sensitivity to TRAIL-induced apoptosis, 
and IAPs’ depletion induces the assembly of the “ripop-
tosome,” thereby triggering cell death.26 Interestingly, 
several players in the GBM tumor paradigm, such as 
VEGF, IL-8, NFκB and STAT5b, have already been 
described as direct targets of TTP genes, while others, 
such as STAT3, PIM1, PIM3 and XIAP, are consid-
ered putative ones, since they carry AU-rich elements 
in their mRNAs’ 3'-UTR. This observation suggests 
that, by acting on the expression of TTP genes, it might 
be possible to impinge on GBM growth, viability and 
chemoresistance by determining the downregulation of 
several oncogenes.
Results
ZFP36 ectopic expression interferes with endogenous 
levels of XIAP, PIM1 and PIM3 in the GBM cell line 
ln827. Ln827 cells express very low levels of ZFP36 and 
were the main tool used for ectopic expression assays. 
Figure 1A–D shows the effect of ZFP36 ectopic expres-
sion on its putative target genes XIAP, PIM1 and PIM3. 
In particular, (A) shows a QRT-PCR measuring the 
ectopic expression of ZFP36 obtained on ln827 cells 
compared with the empty vector-treated population 
(ln827E.V.). (B) is a QRT-PCR performed on the same 
cell populations showing that ln827-ZFP36 cells display 
lower levels of XIAP, PIM1, PIM3 and Stat5b expres-
sion compared with the control population ln827E.V. 
The analysis of Stat5b expression was included as a 
control of ZFP36 activity, since in a previous work it 
was demonstrated that Stat5b is a target of ZFP36.27 
(C and D) show the same results obtained by different 
techniques. In particular, (C) shows a semi quantita-
tive RT-PCR, and (D) depicts different western blots 
Figure 1. overexpression of ZFp36 in the ln827 glioma cell line triggers the 
degradation of the oncogenic kinases pIM1, pIM3 and of the X-linked inhibitor of 
apoptosis (XIAp) mRNAs. (A) the overexpression levels of ZFp36 in ln827 were as-
sessed by quantitative real-time pCR (QRt-pCR). (B) Following ZFp36 overexpres-
sion, the mRNAs of pIM1, pIM3 and XIAp are down-modulated. QRt-pCR data are 
expressed as Log2 of relative quantity compared with the expression levels of the 
same genes in ln827 cells transfected with empty vector. Stat5b has been used as 
a positive control for ZFp36 activity. (C and D) ln827 cell line expresses high levels 
of pIM1, pIM3 and XIAp. (C) Rt-pCR confirms the negative regulation exerted by 
exogenous ZFp36 on the mRNAs of the targets described in this study. (D) In line 
with the decrease in the mRNA levels, western blots following ZFp36 transduction 
show a drop in protein levels of pIM1, pIM3, XIAp and Stat5b compared with the 
e.V. population. All samples were collected 48 h after transfection with pcDNA3.1 
ZFp36/pcDNA3.1 e.V.
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showing that, following ZFP36 ectopic expression, a decrease 
in the expression of PIM1, PIM3, XIAP and Stat5b occurs also 
at the protein level. As a whole, the inverse correlation between 
the expression of PIM1, PIM3, XIAP and ZFP36 together 
with the presence of AREII sequences in their 3' untranslated 
regions (3' UTR) strongly suggests that such genes are indeed 
ZFP36 direct targets.
ZFP36L1 directly binds PIM1, PIM3 and XIAP 3' UTRs 
and thereby affects their stability. Since PIM1, PIM3 and 
XIAP carry AREII-like nonameres in their 3' UTR regions, 
to demonstrate that they are directly targeted by ZFP36, we 
performed a luciferase reporter assay, generating luciferase 
reporter constructs (pGL3-based) allowing transcription of 
a luciferase mRNA carrying the 3' UTRs of PIM1, PIM3 
or XIAP. The results are shown in Figure 2. (A) shows that 
co-expression of the reporter vector encoding PIM1 3' UTR 
with a vector expressing ZFP36 significantly decreases the 
basal reporter activity, demonstrating that by directly binding 
the described mRNA, ZFP36 impairs protein production by 
either promoting mRNA degradation or by inhibiting mRNA 
translation. (B and C) represent the same kind of experiment 
performed by co-expressing ZFP36 with the reporter vectors 
carrying the 3' UTR of PIM3 and XIAP, respectively. Again, 
the assay shows that ZFP36 is capable of directly binding and 
therefore destabilizing the mRNAs of PIM3 and XIAP.
ZFP36 ectopic expression impairs colony formation of 
ln827 cells. To evaluate if, by restoring ZFP36 expression, it 
is possible to impinge on the malignancy of GBM cells, we 
performed a soft agar assay on ln827 cells overexpressing 
ZFP36 (ln827 ZFP36) and compared them to an empty vec-
tor-treated sample (ln827E.V.). The results of such experiment 
are shown in Figure 3. (A) shows two pictures suggesting that 
in the population overexpressing ZFP36, colonies are not only 
less numerous, but also considerably smaller. (B) summarizes 
a series of experiments demonstrating that ZFP36 expression 
determines a consistent reduction of 30% of colonies com-
pared with the control cell population. Since we hypothesized 
that the anti-proliferative or death-inducing effect of ZFP36 
might reside in its capability to downregulate the expres-
sion of target genes such as PIM1, PIM3 and XIAP, we per-
formed soft agar assays on ln827 cells in which these genes 
were silenced and compared them to ln827 cells treated with 
a control siRNA (ctr siRNA). The results of such experiment 
are described in Figure 3C and D. PIM1, PIM3 and XIAP 
were silenced singularly or at the same time. (C) represents a 
QRT-PCR describing the efficacy of the silencing treatments 
in the different populations, while (D) shows the numbers of 
colonies in different sets of experiments. As it was expected, by 
silencing PIM1, PIM3 and XIAP, a decrease in the number of 
colonies is observed by soft agar assay, and, interestingly, the 
cumulative silencing determines the strongest impairment of 
colony formation.
The decreased colony formation depends on cell death 
rather than on slower proliferation. To evaluate whether 
the lower number of colonies observed in the previous assays 
depends on increased cell death or on a lower proliferation 
Figure 2. (A) Luciferase activity assays showing that ZFp36 induces 
decreased expression of mRNAs carrying the 3’ UtR of pIM1, pIM3 or XIAp. 
(A) Luciferase activity was assayed in HeK293 cells transfected with empty 
pcDNA3.1 vector or with pcDNA3.1 vector expressing FlagZFp36 (10 ng) to-
gether with pGL3 reporter construct encoding for a luciferase gene fused 
to the 3’ UtR of pIM1. Similar experiments were performed with pcDNA3.1 
vector expressing FlagZFp36 together with pGL3 reporter construct en-
coding for a luciferase gene fused to the 3’ UtR of pIM3 (B) or XIAp (C). Data 
represent mean and SeM for n = 4, **p < 0.01.
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that the percentage of condensed nuclei is con-
sistently 20% higher in ln827 ZFP36 com-
pared with ln827E.V. To complete this set of 
data, we counted nuclei in ln827 cells that pre-
viously underwent silencing of PIM1, PIM3 
and XIAP. Results are given in (C) and show 
that, in accord with soft agar results, the high-
est death rates are obtained when the target 
genes are inactivated simultaneously, and it 
has to be underlined that the downregulation 
of PIM3 and XIAP seems to be particularly 
relevant in order to induce cell death.
To assess if the observed death depends on 
apoptosis, we performed a TUNEL assay on 
ln827 ZFP36 cells and successively an annexin 
V/PI assay. Results are shown in Figure 5. (A) is 
an immunofluorescence staining of ZFP36 
coupled to the TUNEL assay. Interestingly, a 
small amount of DNA fragmentation is visible 
only in cells ectopically expressing ZFP36. To 
better elucidate the type of cell death, a double 
staining annexin V-propidium iodide was performed. Results 
shown in Figure 5B and C were obtained at time points of 24 and 
48 h after infection. (B) shows that ln827 ZFP36 cells display 
significantly higher levels of both annexin V and PI positivity 
compared with the control population ln827E.V. Nevertheless, 
we were not able to identify any Annexin V single-positive popu-
lation at any time point (data not shown), suggesting that the 
cell death triggered by ZFP36 involves a program which is differ-
ent from classical apoptosis. We monitored to see if comparable 
results could be obtained by silencing PIM1, PIM3 and XIAP in 
rate, we performed cell cycle analysis and growth curves (data 
not shown) suggesting that it is not an impairment of prolifera-
tion underlying the low number of colonies formed by ln827 cells 
ectopically expressing ZFP36. Successively, we evaluated by dif-
ferent techniques the viability of the different cell populations. 
Results of such analysis are summarized in Figures 4 and 5. In 
the first experiment (Fig. 4), we performed a count of condensed 
nuclei, shown in (A), to generally evaluate the number of cells 
supposedly undergoing apoptosis. As far as ln827 cells overex-
pressing ZFP36 are concerned, data are shown in (B), showing 
Figure 3. (A and B) effect of ZFp36 overexpression 
on anchorage independent growth in ln827. After 
infection and selection for stable transduction, 
pBABe e.V. and pBABe ZFp36 cells were plated in 
soft agar. After 21 d colonies were scored. (A) 5x 
magnification phase contrast picture shows 
the morphology of the scored colonies for each 
sample. ZFp36 expression induces a strong reduc-
tion in size of the grown colonies when compared 
with the empty vector population. (B) ZFp36 ex-
pression also impairs the anchorage-independent 
growth of ln827, as demonstrated by the number 
of scored colonies, which is consistently lower in 
the ZFp36 population. (C and D) Anchorage-inde-
pendent growth of ln827 relies on the expression 
of pIM1, pIM3 and XIAp. (C) QRt-pCR is representa-
tive of the efficacy of gene silencing achieved in 
ln827 through pooled oligo siRNAs transfection. 
Control siRNA population was set as calibrator in 
each experiment. (D) siRNA-transfected cells were 
plated in soft agar 72 h after transfection then 
scored 14 d later. As shown in (D), single silencing 
of pIM1, pIM3 or XIAp impairs the colony forma-
tion ability of ln827. the concurrent silencing of 
these genes has a cumulative effect that strongly 
counteracts the colony formation. the bars in 
(B and D) represent SeM for three independent 
experiments, *p < 0.05, **p < 0.01.
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represented in the treated population. To confirm the fact that 
compounds capable of inducing the expression of ZFP36 push 
ln827 cells toward apoptosis, we performed a cell cycle analysis. 
The result of this last assay is shown in Figure 7C, where in the 
part representing ln827C.E., a clear sub-G
1
 peak appears, further 
suggesting that the analyzed population is undergoing cell death.
Discussion
Although it was originally described as an important regulator of 
the inflammatory response, a growing body of publications shows 
that ZFP36 is deficient in cancer cells when compared with nor-
mal cell types,16 and that its expression counteracts malignant 
progression by interfering with different pathways, depending on 
the disease model.34-37
ln827 cells. Data are shown in (C), where the mutual 
gene silencing of the target genes induces high positiv-
ity to annexin V/PI.
Since CASP3 activity was not detected follow-
ing ZFP36 ectopic expression (data not shown), we 
hypothesized that XIAP’s depletion determined by 
ZFP36 could lead to ripoptosome’s aggregation26 and 
subsequent death via CASP8 activation. To verify this 
hypothesis, we performed an immunoblot (Fig. 5D) 
showing that following ZFP36 ectopic expression, 
ln827 cells display RIPK1 stabilization and CASP8 
activation represented by the appearance of low 
molecular weight forms and by a decrease in inten-
sity of the high molecular weight un-cleaved form. 
Interestingly, we were also able to detect by western 
blot an increase of a peculiar form of cleaved PARP-1 
(Fig. 5E), characterized by the appearance of 116, 55 
and 42 KDa bands, compatible with the programmed 
necrotic cell death.38
Ectopic expression of ZFP36 reduces the invasion 
ability of ln827 cells. Since published data suggest 
that inhibition of Stat5b reduces the invasion potential 
of human GBM cells,29 and that PIM3 kinase inhibi-
tors downregulate STAT3(Tyr705) phosphorylation,30 
thereby impinging on the ability of Stat3 to promote 
invasion,31,32 we evaluated whether ectopic expression 
of ZFP36 is capable of reducing invasion by inducing 
the downregulation of Stat5b and PIM3 simultane-
ously. To collect evidences to this regard, we performed 
wound-healing assays on ln827 ZFP36 and compared 
them to ln827E.V. The results are shown in Figure 6A, 
where 72 h after the wound was inflicted, ln827 ZFP36 
do not display the same capability to fill the gap as 
ln827E.V. To demonstrate that the observed impair-
ment in the invasiveness relies on the inactivation of 
specific targets, we performed other wound-healing 
assays, shown in Figure 6B, on ln827 cells in which 
PIM3/XIAP or PIM3/PIM1/XIAP were silenced and 
compared their invasion potential to ln827 treated with 
a control siRNA. As expected, the populations where 
PIM1, PIM3 and XIAP were silenced did not show, 
after 72 h, the same ability of the control population to repair the 
wound, although at a lower extent compared with ZFP36 over-
expression, suggesting that other targets might be involved in the 
inhibition of wound repairing.
Cinnamon polyphenols induce cell death of ln827 cells. To 
further verify the data collected so far, it was elected to test the bio-
logical effect of cinnamon extracts (C.E.), compounds capable of 
inducing the expression of ZFP36 and other members of the same 
gene family27,33 on ln827 cells. The data are described in Figure 7. 
(A) represents a QRT-PCR showing that C.E. induces the expres-
sion of ZFP36. In (B), pictures are shown that demonstrate a 
change in the morphology of ln827 cells treated with C.E. that, 
following the treatment, detach from the plate. Coupled to the 
morphological pictures, (B) also carries the DAPI staining of the 
nuclei clearly showing that condensed apoptotic nuclei are largely 
Figure 4. Condensed nuclei evaluation in ln827e.V./ZFp36 and in ln827 after pIM1, 
pIM3 and XIAp depletion by oligo siRNA strategy. (A) DApI staining of pBABe ZFp36 
and pBABe e.V. ln827. Cells that undergo ZFp36 overexpression show higher number 
of both condensed nuclei and micronuclei when compared with the e.V. population. 
(B) ZFp36 population is characterized by a higher frequency of nuclear condensation 
when compared with the e.V. population. (C) Gene silencing by pooled oligo siRNAs 
of pIM1, pIM3, XIAp reproduces the effect of ZFp36 expression. Again, the multiple si-
lencing of these genes shows to be more effective than the single targeting strategy. 
the graphs in this figure represent the mean and SeM of n = 3 experiments, in each 
of which ten fields were scored for each cell population. the number of condensed 
nuclei over the total number of nuclei gives the percentage shown by the graphs.
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in very different and heterogeneous disease models. For this reason, 
we decided to verify the activity of ZFP36 in GBM cell lines.
GBM is genetically highly heterogeneous, and it still has a 
negative outcome, since no effective therapy has been established. 
The fact that ZFP36 and the other members of this gene family, 
such as ZFP36L1, are capable of inducing the degradation of quite 
a large number of mRNAs, among whom are listed those encoding 
several oncogenes, explains why their targeting seems to be effective 
Figure 5. For figure legend, see page 1983.
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overexpression of ZFP36 determines the downregulation of 
XIAP. We believe that this phenomenon somehow mimics geno-
toxic stress-induced depletion of IAPs and therefore triggers the 
assembly of the ripoptosome. This hypothesis is supported by 
an immunoblot showing that casp8, known as the initiator of 
the extrinsic pathway but now also to be the effector of ripopto-
some-triggered necroptotic cell death, is activated in ln827 cells 
following ZFP36 ectopic expression, and that in the same cells 
there is an increase of RIP1, that might depend on the fact that 
this protein is stabilized when the ripoptosome is assembled. In 
the same cells, we also observed a necrotic cleavage of PARP-1 
that further suggests that the ZFP36 induced cell death of ln827 
GBM cells could depend on a necroptotic cell death program. 
Altogether, these data suggest that by restoring the expression 
of ZFP36, ln827 GBM cells die owing to the activation of two 
Moreover, there is evidence suggesting that ZFP36 
is inactivated in gliomas,17 and we collected further 
evidence (Fig. 1A) that in ln827 GBM cell lines, 
ZFP36 is expressed at very low levels.
Another aspect strengthening the hypothesis that 
targeting ZFP36 could impinge on GBM biology, 
resides on published data suggesting that ZFP36 
negatively regulates EGFr pathway,14 which is partic-
ularly important during the development of the dis-
ease, and that among its targets there’s also Stat5b,27 
whose activity participates in determining the prolif-
erative activity and the invasion capability of GBM 
cells.29 To verify the effect of ZFP36 expression on 
GBM cells, we performed ectopic expression experi-
ments and, while doing so, we demonstrated that the 
kinases PIM1 and PIM3 and X-linked inhibitor of 
apoptosis protein (XIAP) are new ZFP36 targets.
PIM family’s serine/threonine kinases play an 
important role in cancer biology. Whereas elevated 
levels of PIM1 and PIM2 are mostly found in hema-
tologic malignancies and prostate cancer, increased 
PIM3 expression is observed in different solid 
tumors.38 PIM1 and PIM3 are active as oncogenes 
when their expression increases, owing to a loss of 
regulation; therefore, it was reasonable to think 
that by inducing the expression of a gene capable of 
determining their downregulation, ZFP36, by the 
hypothesis, would be possible to counteract their 
oncogenic activity. Among other activities, PIM1 
and PIM3 act by repressing apoptosis30,39,40 and by 
stimulating the invasion activity of cancer cells.41 
These characteristics are reflected in the gene silenc-
ing experiments shown here, where downregulation of PIM1 and 
PIM3 expression determines cell death and a decrease of inva-
siveness. In particular, as far as GBM cells are concerned, PIM3 
seems to be more relevant than PIM1.
XIAP is a E3 ubiquitine ligase, member of the IAP family, 
whose other member cIAP2 had already been characterized 
as a target of ZFP36.42 Although it is clear that IAPs are fre-
quently deregulated in cancer, less clear is how they exert their 
pro-tumorigenic effect. Recent data suggest that the E3 ubiqui-
tine ligase activity of IAPs directly influence the assembly of a 
large death-inducing platform called “ripoptosome”43 by acting 
on the stability of the RIP1 kinase. Ripoptosome contains the 
core components RIP1, FADD and caspase-8 and assembles in 
response to genotoxic stress-induced depletion of at least two 
members among XIAP, cIAP1 and cIAP2. Here we show that 
Figure 5 (See opposite page). ZFp36-mediated inhibition of pIM1, pIM3 and XIAp induces cell death of glioma cells. (A) transfected ln827 cells were 
plated on coverslips, and 48 h after transfection, they were subjected to tUNeL assay. positive staining is detected only in the ZFp36-expressing popu-
lation. (B) Cell death was measured at different time points after transduction as the proportion of cells positive for Annexin V and propidium iodide. 
Annexin V values are graphed on the y axis, while pI values are on the x axis. the numbers in the lower right corners represent the percentage of posi-
tive cells. Ln827 ZFp36 show increased percentage of both AnnexinV/pI double positive and pI single positive cells. (C) oligo siRNA transfection of the 
glioma cell line was performed as described and apoptosis was assessed by Annexin V/pI staining. the single silencing of pIM1, pIM3 and XIAp induces 
positivity to the apoptotic markers but is less efficient than the simultaneous multiple gene silencing, which strongly increases the percentage of the 
Annexin V/pI double positive population. (D) Western blot analysis shows caspase 8 cleavage and concomitant increase of the RIp1 kinase upon ZFp36 
expression. (e) Western blot analysis of pARp-1 shows the appearance of 55 KDa and 42 KDa bands in the ln827 ZFp36 population.
Figure 6. Migration of glioma cells is inhibited by ZFp36 through downregulation 
of pIM3 and XIAp. (A and B) Wound-healing assay was performed as described and 
cells were checked every 24 h. Similar results were obtained in three independent 
experiments. ZFp36 expressing cells show a relevant impairment of their migration 
potential. Silencing of pIM3 and XIAp partially recapitulates this effect.
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while developing new approaches for GBM depend on its het-
erogeneity, it could be possible to obtain encouraging results by 
using chemicals capable of inducing the expression of ZFP36. 
This hypothesis is sustained by the data shown in the last part of 
the study, showing the effect of cinnamon polyphenols on GBM 
cells.
Another finding, although merely speculative, that neverthe-
less deserves to be underlined, regards the ripoptosome. Although 
so far it was known that this structure appears in response to 
genotoxic stress, we provide evidence that it might be assembled 
also following ZFP36 expression in specific cell contexts, and 
therefore it might represent not only a phenomenon induced by 
cytotoxic treatments but it could be a physiological event trig-
gered by specific molecular pathways that surely deserve further 
investigation.
Materials and Methods
Cell cultures and treatments. The human glioma cell line 
ln827 was cultured in DMEM medium (Euroclone) sup-
plemented with 10% heat-inactivated fetal bovine serum 
(Biowhittaker), 2 mM L-glutamine and penicillin/streptomy-
cin (100 μg/ ml) (Euroclone). GP + envAm12 cells and human 
embryonic kidney (HEK) 293 cells were obtained from ATCC 
and cultured in DMEM medium (Euroclone) supplemented 
with 10% heat-inactivated fetal bovine serum (Biowhittaker), 
1 mM L-glutamine and penicillin/streptomycin (100 μg/
ml) (Euroclone). Ecotropic Phoenix cells were cultured in 
IMDM medium supplemented with 10% heat-inactivated fetal 
bovine serum, 1 mM L-glutamine and penicillin/streptomycin 
(100 μg/ ml) (Euroclone).
Cinnamon polyphenol extracts were solubilized in DMSO, 
then added to complete culture medium at the final concentra-
tion of 0.25 μg/μl. The medium was not changed until cells were 
lysed or colonies were scored.
Plasmids and retroviral vectors. Full-length ZFP36 was gen-
erated by RT-PCR as already described in reference 27. EcoRI 
was digested and subsequently cloned within the EcoRI ends of 
pBABE puro retroviral vector or of pcDNA3.1 expression con-
struct, resulting, respectively, in pBABE ZFP36 and pcDNA3.1 
ZFP36 constructs. FlagZFP36 fragment was RT-PCR ampli-
fied using FlagZFP36-Direct Primer (DP) (5'-ATG GAC TAC 
AAA GAT GAC GAC GAC AAG GAT CTG ACT GCC ATC 
TAC-3') and ZFP36-Reverse Primer (RP) (5'-CGG GCA GTC 
ACT TTG TCA CT-3'), and the amplified fragments were 
inserted into the pCR2.1-TOPO T/A cloning vector, from which 
they were EcoRI excised and cloned into an EcoRI-digested 
pcDNA3.1 vector.
PIM1, PIM3 and XIAP ARE-containing 3' UTR were ampli-
fied by RT-PCR on total RNA extracted from ln827 cells using 
PIM1 3' UTR-DP (5'-ATG CGC ATT CTA ACC TGG AG-3') 
and PIM1 3'UTR RP (5'-GAT CTC TTT TAT TCC CCT GTA 
CAG TAT TT-3'), PIM3 3' UTR-DP (5'-GCA CAC ACA ATG 
CAA GTC CT-3') and PIM3 3' UTR RP (5'-ACT GAA AGA 
ACC CCC ATC TG-3'), XIAP 3'UTR DP (5'-TTC ATA GAA 
CGT CCA GGG TTT A-3') and XIAP 3' UTR RP(5'-GAA 
distinct death pathways, the one in which PIM1 and PIM3 are 
involved and another, which is triggered by XIAP’s (and cIAP) 
depletion. Again, this hypothesis is sustained by the silencing 
experiments, showing that the inactivation of PIM1, PIM3 and 
XIAP at once is way more effective in inducing cell death than 
the single inactivation of the three genes, suggesting that the 
cumulative effect depends on the activation of different pathways 
leading to the same biological result, rather than on the interfer-
ence with a single, common pathway.
Besides the demonstration of new ZFP36 target genes, one 
of the central findings of this work is that ZFP36 is an element 
that deserves to be considered for the development of future 
GBM therapies. In fact, since many difficulties encountered 
Figure 7. Cinnamon polyphenols treatment of glioma cells induces 
ZFp36 expression and reduces cells growth. (A) Increase of ZFp36 
expression in ln827 was detected by QRt-pCR after 24 h cinnamon 
polyphenols treatment at the concentration of 0.25 μg/μl. the vehicle-
treated sample was used as calibrator for the basal ZFp36 expression 
levels. (B) phase contrast images on the left depict the morphology 
of cinnamon treated glioma at 24 h treatment. Detachment from the 
vessel is clearly visible in the lower picture. on the right DApI stain-
ing of similarly treated cells shows an increase of the percentage of 
condensed nuclei. (C) Cell cycle analysis after 24 h of treatment with 
polyphenols shows the onset of a sub G1 peak and an increase in the 
G2/M phase.D
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PRISM 7900 sequence detection system (Applied Biosystems). 
Primers and probes for the different genes’ amplification were 
provided by Applied Biosystems; quantitation was performed by 
amplifying GAPDH mRNA as endogenous control.
Antibodies and western blots. Cells were lysed with RIPA 
buffer containing 50 mM TRIS-HCl (pH 7.4), 150 mM NaCl, 
1% NP-40, 1 mM sodium deoxycholate, 1 mM sodium orthovan-
adate and with added 1 mM EDTA and Complete Protease 
Inhibitor Cocktail (Roche Applied Science); vortexed for 5 sec; 
and centrifuged at 16,100 g for 30 min at 4°C. Equal amounts 
of protein were loaded onto 10–12% SDS-polyacrylamide gel, 
separated by electrophoresis, and transferred to nitrocellulose 
membranes (GE Healthcare). Expression of actin was analyzed 
with a mouse anti-human pan-actin MoAb (Sigma-Aldrich) to 
normalize protein samples. Membranes were probed with ZFP36 
polyclonal antibody (Abcam, ab36558), PIM1 polyclonal anti-
body (Abcam, ab66767), PIM3 polyclonal antibody (Abcam, 
ab71321), XIAP (Cell Signaling, #2042), Stat5b (G-2) monoclo-
nal antibody (Santa Cruz Biotechnology, sc-1656), RIP1 mouse 
monoclonal antibody (BD Transduction Laboratories, 610458), 
Caspase-8 monoclonal antibody (Cell Signaling, 9746). Blots 
were then incubated either with anti-rabbit (Cell Signaling,  7074) 
or anti-mouse (Santa Cruz Biotechnology, sc-2005) IgG-HRP 
antibodies and detected using BM Chemiluinescence Blotting 
Substrate (Roche Applied Science).
Immunofluorescence. Briefly, cells cultured on coverslips 
were fixed with 4% paraformaldehyde for 10 min and permea-
bilized with 0.1% Triton-X 100/PBS for 3 min. Following incu-
bation with ZFP36 primary antibody, cells were washed and 
incubated with fluorescently labeled secondary antibody Alexa 
Fluor® 568 (Invitrogen). Finally, nuclei were counterstained by 
DAPI (Sigma-Aldrich), and slides were analyzed using a Carl 
Zeiss Axioskop 40 fluorescent microscope (Carl Zeiss).
Anchorage-independent growth and migration assays. 
Anchorage-independent growth assays were performed in trip-
licate in 35 mm well plates. 3 x 103 cells per well were seeded in 
DMEM + 10% FBS containing 0.3% low-melting agarose on 
the top of the bottom agar containing 0.5% low-melting agarose 
DMEM + 10% FBS. After 14–21 d colonies were counted. Error 
bars represent SEM calculated on a set of three to four indepen-
dent experiments (*p < 0.05; **p < 0.01). ZFP36 overexpressing 
cells were first selected by means of puromicyn treatment and 
then seeded in absence of any selection agent. siRNA transfected 
ln827 were seeded 72 h after siRNA transfection. For migration 
assays, cells were cultured at confluence in 24-well plates and 
then scratched with a thin disposable tip to generate a wound in 
the cell monolayer. Wound healing was assessed every 24 h by 
light microscope.
Cell death assays. Apoptotic nuclei were detected by TdT-
mediated dUTP terminal nick-end labeling kit (TUNEL) 
(Roche Applied Science) or by DAPI staining. AnnexinV/PI 
positivity of indicated cells was assessed by BD PharMingenTM 
kit (cat. Number 556547). To monitor cell cycle, 1 x 105 cells 
were suspended in 500 μl hypotonic solution (50 μg/ml PI, 0.1% 
sodium citrate, 0.1% Triton X-100) and then placed at 4°C in the 
dark for 10 min before flow cytometry analysis.
GCT GAG GCA CGA GAA TC-3'). The amplified fragments 
were then inserted into the pCR2.1-TOPO T/A cloning vec-
tor and were fully sequenced. The 3' UTR fragments were then 
EcoRI excised, blunted and cloned in the sense orientation into 
a SmaI-digested pGL3-Promoter Vector (Promega) that had pre-
viously been modified in order to transfer the multiple cloning 
region downstream the luciferase reporter gene.
DNA transfection and retroviral infection. Transient trans-
fection of pcDNA3.1-based constructs was performed using 
Fugene HD reagent (Roche Applied Science) as suggested by the 
manufacturer’s guidelines. The ln827 cell line was transduced 
using pBABE empty control vector or pBABE ZFP36 retrovi-
ral vector. Packaging lines for the pBABE-based constructs were 
generated by transinfection in the ecotropic Phoenix and suc-
cessive infection of amphotropic GP + envAm12 cells. Stable 
packaging cell lines were then produced by 1 μg/ml puromy-
cin selection. Ln827 were transduced by two cycles of infection 
(6 h each) with viral supernatant in the presence of polybrene 
(8 μg/ml). Transduced ln827 were selected by mean of one cycle 
of 0.5 μg/ ml puromycin treatment.
Gene silencing. Ln827 cells were treated with Lipofectamine 
RNAiMAX (Invitrogen) reagent and transfected with a mix of 
three predesigned siRNAs as per the manufacturer’s instruc-
tions. PIM1 siRNAs (Hs01_00073783, Hs01_00073785, 
Hs01_00073786, Sigma Aldrich); PIM3 siRNAs 
(Hs01_00152603, Hs01_00152604, Hs01_00152605, Sigma 
Aldrich); XIAP siRNAs (Hs02_00331284, Hs02_00175694, 
Hs02_00175695, Sigma Aldrich) or control siRNA (Sigma 
Aldrich). After 18 h, the medium was replaced with complete 
DMEM medium. Cells were processed 72 h after transfection.
RT-PCR and real-time PCR. Total cellular RNA was 
extracted using the EuroGOLD Total RNA kit (Euroclone) 
or RNeasy MicroKit (Qiagen). RNA integrity and concentra-
tion was then assessed by the Bio-Analyzer technique (Applied 
Biosystems).
For RT-PCR, 3 μg of total RNA were reverse transcribed 
using M-MLV reverse transcriptase (Invitrogen), and then 
expression of specific genes was assessed by PCR amplification 
performed using specific primers: GAPDH-DP (5'-GAA GGT 
GAA GGT CGG AGT C-3'), GAPDH-RP (5'-GAA GGC 
CAT GCC AGT GAG CT-3'); ZFP36 DP (5'-ATG GAT CTG 
ACT GCC ATC TAC-3') ZFP36 RP (5'-CGG GCA GTC ACT 
TTG TCA CT-3'); PIM1 3' UTR-DP (5'-ATG CGC ATT CTA 
ACC TGG AG-3') and PIM1 3' UTR RP (5'-GAT CTC TTT 
TAT TCC CCT GTA CAG TAT TT-3'), PIM3 3' UTR-DP 
(5'-GCA CAC ACA ATG CAA GTC CT-3') and PIM3 3' UTR 
RP (5'-ACTGAAAGAACCCCCATCTG-3'), XIAP 3' UTR 
DP (5'-TTC ATA GAA CGT CCA GGG TTT A-3') and XIAP 
3' UTR RP (5'-GAA GCT GAG GCA CGA GAA TC-3'). 
Normalization of the amplified samples was obtained by the 
glyceraldehydes-3-phosphate dehydrogenase (GAPDH) house-
keeping gene.
For quantitative real-time PCR (QRT-PCR) 100 ng of total 
RNA were reverse-transcribed using the High-Capacity cDNA 
Archive Kit (Applied Biosystems) according to the manufac-
turer’s instructions; QRT-PCR was then performed with an ABI 
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powder were then suspended in methanol/water (50/50 v/v; 
20 ml) and extracted in ultrasound water bath at room tempera-
ture for 30 min. The suspension was centrifuged (4,000 rpm), 
the supernatant was removed, and the solid was extracted again 
using the same procedure. Liquid phases were then collected and 
evaporated in vacuo at room temperature to get rid of metha-
nol and finally subjected to freeze drying. The extract yield was 
6.1%. All chemicals were reagent grade and used without further 
purification; they were purchased from Sigma-Aldrich.
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Luciferase assays. HEK293 cells were plated at a density 
of 50,000 cells/well 12 h before transfection in 24-well plates. 
Transfections were carried using Fugene HD reagent (Roche 
Applied Science). In a typical assay, each well received 200 ng of 
pGL3-based reporter construct, 200 ng of CMV-b-galactosidase 
plasmid (Clontech Laboratories) and 10 ng of pcDNA3.1 
FlagZfp36, as indicated in figure legends; the difference in total 
amount of transfected DNA was scaled up with pcDNA3.1 
empty vector. After 24 h, cells were harvested. and cell lysates 
were assayed for luciferase and b-galactosidase activity. Each 
transfection was done in duplicate in the same experiment, and 
the plotted luciferase activities represent the average of four differ-
ent experiments; error bars represent SEM (*p < 0.05; **p < 0.01).
Preparation of cinnamon extract. Dried cinnamon 
(Cinnamomun zeylanicum) was crushed in a mortar. Five g of 
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